UNILEVER has ruled out a fourth bid for the consumer healthcare business of drugs giant GSK, after its third offer of £50billion was knocked back. GSK said that the unsolicited bids for its consumer healthcare business, which is best known for its Panadol, Sensodyne and Nicorette brands, had “fundamentally undervalued” its prospects.
Daily Express :: City and Business Feed
